Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety, tolerability, and pharmacology of darifenacin in patients with amyotrophic lateral sclerosis, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darifenacin (darifenacin)

Snippet

Sponsor: Oliver Blanchard | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: RECRUITING